Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dystroglycan does not contribute significantly to kidney development or function, in health or after injury

6 Jan 2011

Abstract excerpt

Dystroglycan (DG or DAG1) is considered a critical link between the basement membrane and the cytoskeleton in multiple tissues. DG consists of two subunits, an extracellular α-subunit that binds laminin and other basement membrane components, and a transmembrane β-subunit. DG-null mouse embryos die during early embryogenesis because DG is required for Reichert's membrane formation. DG also forms an integral part...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Muscle Physiology and Disorders
Share to Nuclear Structure and Function
Share to Renal Diseases and Glomerulopathies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 21209007
DOI: 10.1152/ajprenal.00725.2010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dystroglycan does not contribute significantly to kidney development or function, in health or after injuryPMID 21209007Read ↗

Dystroglycan Is Essential for Early Embryonic Development: Disruption of Reichert's Membrane in Dag1-Null MiceSemantic proximity Read ↗

Models for studies of proteoglycans in kidney pathophysiology.Semantic proximity Read ↗

Removal of dystroglycan causes severe muscular dystrophy in zebrafish embryosSemantic proximity Read ↗

A missense mutation (C667F) in β-dystroglycan results in reduced dystroglycan protein levels leading to myopathy and destabilization of the blood-brain and blood-retinal barrier protein networkSemantic proximity Read ↗

The dystroglycan complex: From biology to cancerSemantic proximity Read ↗

The many roles of dystroglycan in nervous system development and functionSemantic proximity Read ↗

The missense mutation C667F in murine β-dystroglycan causes embryonic lethality, myopathy and blood-brain barrier destabilization.Semantic proximity Read ↗

Deficiency of the Planar Cell Polarity Protein Vangl2 in Podocytes Affects Glomerular Morphogenesis and Increases Susceptibility to InjurySemantic proximity Read ↗

The Importance of Podocyte Adhesion for a Healthy GlomerulusSemantic proximity Read ↗

Repair Problems in Podocytes: Wnt, Notch, and GlomerulosclerosisSemantic proximity Read ↗

Scaffolding Proteins DLG1 and CASK Cooperate to Maintain the Nephron Progenitor Population during Kidney DevelopmentSemantic proximity Read ↗

Notch signaling in kidney development.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.